Here, we demonstrate that the delivery of Cas9 mRNA via a cationic lipid polymer (lipoplex) targets the TM selectively and edits the MYOC gene, thereby rescuing a mouse model of glaucoma. This evidence concerns the gene MYOC and glaucoma.